Press Releases

DUBAI, UAE, May 1, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ:AIIO) recently filed its annual financial report for the year 2025. Benjamin Zhai, the Chief Executive Officer, issued a letter to investors and strategic partners detailing the company's strategic reorganization and operational progress since the new management team assumed their roles in May 2025. In the AI software segment, the company is advancing its partnership with DaBoss, a Silicon Valley-based AI model data service provider. Operations for intelligent data training and collection are underway across multiple l

LAUSANNE, Switzerland, May 1, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE:ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to purchase an aggregate of 49,400 of the Company's common shares to two new employees on May 1, 2026 (each, a "Grant"). The Grants were offered as material inducement to the employees' employment. The grants were approved by the Compensation Committee of the Company's Board of Directors pursuant to the Company's Inducement Plan to motivate and

Latest findings from the DME AWARE Delphi Study on unmet needs in diabetic macular edema (DME) management highlighting the need for non-invasive therapeutic options to be presented by Baruch Kuppermann, M.D., Ph.D.New post-hoc analysis of OCT scans on GCIPL and analysis of responders with improvement of 15 or 30-letter on low-contrast visual acuity (LCVA) from the Phase 2 ACUITY trial with Privosegtor, to be presented by Martin Zinkernagel, M.D., Ph.D.Corporate update on Oculis' pipeline and upcoming milestones to be presented by Riad Sherif, M.D., CEO of Oculis at Eyecelerator ZUG, Switzerland, May 01, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (NASDAQ:OCS) (Oculis), a global bioph

Charles Schwab Foundation commits more than $20 million supporting youth financial education over the next three years Charles Schwab today kicked off the second annual National Investing Day, bringing together organizations from the financial industry and nonprofit community to participate in the day dedicated to investor education and empowerment. National Investing Day is grounded in a simple idea: while millions of Americans participate in the markets, many still lack the confidence or resources to see themselves as investors. Expanding access to credible, early education remains a critical step in closing that gap. Now in its second year, National Investing Day is building momentum

GUANGZHOU, China, May 1, 2026 /PRNewswire/ -- XPeng Inc. ((", XPENG", or the ", Company, ", NYSE:XPEV), a leading global AI mobility technology company, today announced its vehicle delivery results for April 2026. In April, XPENG delivered a total of 31,011 vehicles, representing a 13% increase from the prior month.Furthermore, following the official rollout of VLA 2.0 in March, test-drive satisfaction rates at XPENG retail stores recorded a significant increase by the end of April. The average time customers take to make a purchase decision after a test drive also decreased by 44.7% month-over-month, reinforcing intelligent driving as a key driver of sales growth.On April 15, 2026, the Comp

Continued execution drives good Q1 result. On track to deliver 2026 guidance. HighlightsUnderlying Group sales up 4% in Q1. All business units performing in line with expectations; continued strong performance in Virtual Learning with underlying sales up 21%, and Assessment & Qualifications expected to return to growth from Q2.On track to deliver 2026 full year guidance. Continued progress against our 2026 priorities, including: Advancing core business and enterprise power metrics, with an Enterprise strategic partnership with Salesforce and US Student Assessment contract win in Wyoming (link here). Leading with the application of innovative technologies, including the roll out of Communicat

Clinical results of KSI-101 in macular edema secondary to inflammation (MESI) from a tertiary care uveitis practice demonstrate outcomes consistent with results from the U.S. Phase 1b APEX study, supporting continued global development and expansion of the Phase 3 PEAK and PINNACLE program into Asia.Ongoing advancement of bispecific therapies in geographic atrophy and ocular inflammatory disease; preclinical data continue to support a multi-target approach to address limitations of current single-target therapies. The ABCD PlatformTM, an evolution of Kodiak's ABC platform to include conjugation of small molecules and other drugs, continues to advance as a versatile system for targeted, multi

29,356 vehicles were delivered in April 2026, increasing by 22.8% year-over-year112,821 vehicles were delivered year-to-date in 2026, increasing by 71.0% year-over-yearCumulative deliveries reached 1,110,413 as of April 30, 2026 SHANGHAI, May 01, 2026 (GLOBE NEWSWIRE) -- NIO Inc. (NYSE:NIO, HKEX: 9866, SGX: NIO)) ("NIO" or the "Company"), a pioneer and a leading company in the global smart electric vehicle market, today announced its April 2026 delivery results. The Company delivered 29,356 vehicles in April 2026, representing an increase of 22.8% year-over-year. The deliveries consisted of 19,024 vehicles from the Company's premium smart electric vehicle brand NIO, 5,352 vehicles from t

Amkor Technology, Inc. (NASDAQ:AMKR) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0.00% convertible senior notes due 2031 (the "notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The notes will be fully and unconditionally guaranteed, on a senior, unsecured basis, by each subsidiary of Amkor that currently or in the future guarantees its 5.875% senior notes due 2033 (the "guarantors"). The issuance and sale of the notes are scheduled to settle on May 5, 2026, subject to customary closing conditions. Amkor als

TORONTO and VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- McEwen Inc. ("McEwen") (NYSE/TSX:MUX) and Golden Lake Exploration Inc. ("Golden Lake") (CSE:GLM) (OTCQB:GOLXF) are pleased to announce the completion of the previously announced business combination between McEwen and Golden Lake by way of statutory plan of arrangement (the "Arrangement"). Golden Lake's principal asset is its Jewel Ridge and Jewel Ridge West projects located adjacent to McEwen's Windfall and Lookout Mountain discoveries, part of the Gold Bar Mine Complex, in the Eureka Mining District of Nevada. Historical drill highlights from Jewel Ridge project include 2.20 gpt gold over 28.96 meters, 1.24 gpt

BEIJING, China, May 01, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced that it delivered 34,085 vehicles in April 2026. As of April 30, 2026, Li Auto's cumulative deliveries reached 1,669,442. In April, the all-new Li L9 Livis debuted at the 2026 Beijing International Automotive Exhibition, with its official launch scheduled for May 15. The launch event will fully showcase the vehicle's latest advancements in exterior and interior design, chassis and suspension, range extension system, safety, and intelligence. As of April 30, 2026, the Company had 511 retail stores in 160 cities,

GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ:SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the pricing of an underwritten public offering of 8,000,000 shares of common stock at a price to the public of $5.00 per share, and in lieu of common stock, to certain investors, pre-funded warrants to purchase 8,000,000 shares of common stock at a purchase price of $4.999 per pre-funded warrant share, which equals the public offering price per share of the common stock less the $0.001 exercise pr

ODAC overwhelming majority voted that TRUQAP plus abiraterone and ADT demonstrated a favorable benefit risk profile for patients based on the CAPItello-281 Phase III trial results First and only targeted treatment combination to demonstrate benefit in this subtype of prostate cancer addresses significant unmet patient need The US Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) has recognized a favorable benefit risk profile for AstraZeneca's TRUQAP® (capivasertib) in combination with abiraterone and androgen deprivation therapy (ADT) for the treatment of patients with PTEN-deficient metastatic hormone-sensitive prostate cancer (mHSPC), based on the CAPItel

Delivers amended offer to TWO Board allowing stockholders to elect $12.00 per share in cash ($0.70 per share more, or more than 6% higher, than CrossCountry Mortgage) or 2.3328 shares of UWMC common stock with no cap or proration on the amount of cash Urges Two Harbors stockholders to tell the TWO Board that it must exercise its fiduciary duty to maximize value for its stockholders and negotiate in good faith with UWMC UWMC provides additional detail on its prior offer not previously disclosed by the TWO board, the amended offer delivered today and why UWMC's new offer is so clearly superior UWM Holdings Corporation ("UWMC") (NYSE:UWMC), today issued an open letter to the stockhol

Event to be held at 9:00 AM ET on Friday, May 1, 2026 Pershing Square Inc. (NYSE:PS) ("Pershing Square") today announced that Pershing Square CEO Bill Ackman and CIO Ryan Israel will host a live Spaces event on X on Friday, May 1 at 9:00 AM ET to discuss the recently completed combined initial public offerings of PS and Pershing Square USA, Ltd. (NYSE:PSUS). The Spaces event on X will be open to the public and provide the opportunity for participants to ask questions and engage in dialogue with Bill and Ryan regarding PS and PSUS. The X Spaces event will be available at https://x.com/BillAckman. About Pershing Square Inc. Pershing Square Inc. is the parent company of Pershing Squa

PSH to Benefit from Reduction of Performance Fees Pershing Square Holdings, Ltd. (LN: PSH) (LN: PSHD) today noted the closing of the initial public offering of the common shares of beneficial interest of Pershing Square USA, Ltd. (NYSE:PSUS), a NYSE-listed U.S. fund managed by PSH's investment manager, Pershing Square Capital Management, L.P. (the "Investment Manager"), as well as the concurrent closing of the initial public offering of the common stock of the Investment Manager's parent company, Pershing Square Inc. (NYSE:PS). PSH and its shareholders will benefit from the initial public offering of PSUS, which was completed with an aggregate offering size of $5 billion, since PSH's am

Viking Recognized on the Annual TIME100 List Honoring Companies Making an Extraordinary Impact Around the World Viking® (www.viking.com) (NYSE:VIK) today announced it has been named to TIME's 2026 TIME100 Most Influential Companies list, which recognizes companies making an extraordinary impact around the world. Viking was recognized in the "Disrupters" category, highlighting companies that are redefining industries and challenging conventional approaches. Viking was also named to the TIME100 Companies: Industry Leaders list for Travel & Tourism, which highlights the 10 most influential companies shaping the sector in 2026. This press release features multimedia. View the full release he

AUSTIN, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics, Inc. ("Rein" or the "Company") (NASDAQ:RNTX), a clinical-stage biopharmaceutical company advancing a novel pipeline of first-in-class medicines for orphan pulmonary and fibrosis indications, today announced the pricing of its underwritten public offering of fifty million shares of its common stock at a public offering price of $1.00 per share for aggregate gross proceeds of $50 million, prior to deducting underwriting discounts and commissions and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 7.5M shares of common stock at the public offering

WILMINGTON, Del., April 30, 2026 /PRNewswire/ -- Oak-Eagle AcquireCo, Inc. (the "Offeror") announced today the extension of the Expiration Time and Settlement Date for the previously announced offers to purchase for cash (each, a "Tender Offer" and, together, the "Tender Offers") any and all of Electronic Arts Inc.'s (NASDAQ:EA) (the "Company") outstanding (i) 1.850% Senior Notes due 2031 (the "2031 Notes") and (ii) 2.950% Senior Notes due 2051 (the "2051 Notes" and, together with the 2031 Notes, the "Notes"), and solicitations of consents (each, a "Consent Solicitation" and, together, the "Consent Solicitations") from holders of the Notes (each, a "Holder" and, collectively, the "Holders")

VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- Taseko Mines Limited (TSX:TKO, NYSE:TGB, LSE: TKO)) (the "Company") will release its first quarter 2026 financial results after market close on Wednesday, May 6, 2026. The Company will host a telephone conference call and live webcast on Thursday, May 7, 2026, at 11:00 a.m. Eastern Time (8:00 a.m. Pacific) to discuss these results. After opening remarks by management, there will be a question and answer session open to analysts and investors. The conference call may be accessed by dialing 800-715-9871 toll free or 646-307-1963, using the access code 3266924. The webcast may be accessed at tasekomines.com/investors/events an